Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-κB activation in TPA-induced breast cancer cells

Journal of Cellular Biochemistry

Volumn 113, Issue 12, 2012, Pages 3653-3662

  Park, Sun Young ^a   Kim, Young Hun ^a   Kim, Younghee ^a   Lee, Sang Joon ^a  

^a Pusan National University   (South Korea)

Author keywords

AR TURMERONE; INVASION; MMP 9; NF B; TPA

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATIC COMPOUND; AROMATIC TURMERONE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TURMERONE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; COLONY FORMATION; CONTROLLED STUDY; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CURCUMA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KETONES; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; RNA, SMALL INTERFERING; SESQUITERPENES; TETRADECANOYLPHORBOL ACETATE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFECTION;

EID: 84866935534     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24238     Document Type: Article

References (32)

1. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB,. 2008. Curcumin and cancer: An "old-age" disease with an "age-old" solution. Cancer Lett 267: 133-164.
2. Aratanechemuge Y, Komiya T, Moteki H, Katsuzaki H, Imai K, Hibasami H,. 2002. Selective induction of apoptosis by ar-turmerone isolated from turmeric (Curcuma longa L) in two human leukemia cell lines, but not in human stomach cancer cell line. Int J Mol Med 9: 481-484.
3. Brinckerhoff CE, Matrisian LM,. 2002. Matrix metalloproteinases: A tail of a frog that became a prince. Nat Rev Mol Cell Biol 3: 207-214.
4. Cho HJ, Kang JH, Kwak JY, Lee TS, Lee IS, Park NG, Nakajima H, Magae J, Chang YC,. 2007. Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms. Carcinogenesis 28: 1104-1110.
5. Chou YC, Sheu JR, Chung CL, Chen CY, Lin FL, Hsu MJ, Kuo YH, Hsiao G,. 2010. Nuclear-targeted inhibition of NF-kappaB on MMP-9 production by N-2-(4-bromophenyl) ethyl caffeamide in human monocytic cells. Chem Biol Interact 184: 403-412.
6. Egeblad M, Werb Z,. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174.
7. Garg A, Aggarwal BB,. 2002. Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 16: 1053-1068.
8. Huang X, Chen S, Xu L, Liu Y, Deb DK, Platanias LC, Bergan RC,. 2005. Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Res 65: 3470-3478.
9. Ishizaki T, Katsumata K, Tsuchida A, Wada T, Mori Y, Hisada M, Kawakita H, Aoki T,. 2006. Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity. Int J Mol Med 17: 357-362.
10. Jemal A, Siegel R, Xu J, Ward E,. 2010. Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
11. Jeong MA, Lee KW, Yoon DY, Lee HJ,. 2007. Jaceosidin, a pharmacologically active flavone derived from Artemisia argyi, inhibits phorbol-ester-induced upregulation of COX-2 and MMP-9 by blocking phosphorylation of ERK-1 and -2 in cultured human mammary epithelial cells. Ann N Y Acad Sci 1095: 458-466.
12. Johnson KD, Bresnick EH,. 2002. Dissecting long-range transcriptional mechanisms by chromatin immunoprecipitation. Methods 26: 27-36.
13. Kim JH, Lee KW, Lee MW, Lee HJ, Kim SH, Surh YJ,. 2006. Hirsutenone inhibits phorbol ester-induced upregulation of COX-2 and MMP-9 in cultured human mammary epithelial cells: NF-kappaB as a potential molecular target. FEBS Lett 580: 385-392.
14. Kim S, Kim SH, Hur SM, Lee SK, Kim WW, Kim JS, Kim JH, Choe JH, Nam SJ, Lee JE, Yang JH,. 2009. Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells. J Ethnopharmacol 126: 252-257.
15. Kwak YE, Jeon NK, Kim J, Lee EJ,. 2007. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma. Ann N Y Acad Sci 1095: 99-112.
16. Larkins TL, Nowell M, Singh S, Sanford GL,. 2006. Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer 6: 181.
17. Lee HS,. 2006. Antiplatelet property of Curcuma longa L. rhizome-derived ar-turmerone. Bioresour Technol 97: 1372-1376.
18. Liotta LA, Steeg PS, Stetler-Stevenson WG,. 1991. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64: 327-336.
19. O-charoenrat P, Wongkajornsilp A, Rhys-Evans PH, Eccles SA,. 2004. Signaling pathways required for matrix metalloproteinase-9 induction by betacellulin in head-and-neck squamous carcinoma cells. Int J Cancer 111: 174-183.
20. Prakash P, Misra A, Surin WR, Jain M, Bhatta RS, Pal R, Raj K, Barthwal MK, Dikshit M,. 2011. Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis. Thromb Res 127: 111-118.
21. Ralhan R, Pandey MK, Aggarwal BB,. 2009. Nuclear factor-kappa B links carcinogenic and chemopreventive agents. Front Biosci (Schol Ed) 1: 45-60.
22. Ratovitski EA,. 2010. LKB1/PEA3/DeltaNp63 pathway regulates PTGS-2 (COX-2) transcription in lung cancer cells upon cigarette smoke exposure. Oxid Med Cell Longev 3: 317-324.
23. Roy R, Yang J, Moses MA,. 2009. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 27: 5287-5297.
24. Shin Y, Yoon SH, Choe EY, Cho SH, Woo CH, Rho JY, Kim JH,. 2007. PMA-induced up-regulation of MMP-9 is regulated by a PKCalpha-NF-kappaB cascade in human lung epithelial cells. Exp Mol Med 39: 97-105.
25. Singh G, Kapoor IP, Singh P, de Heluani CS, de Lampasona MP, Catalan CA,. 2010. Comparative study of chemical composition and antioxidant activity of fresh and dry rhizomes of turmeric (Curcuma longa Linn.). Food Chem Toxicol 48: 1026-1031.
26. Takada Y, Aggarwal BB,. 2003. Betulinic acid suppresses carcinogen-induced NF-kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: Abrogation of cyclooxygenase-2 and matrix metalloprotease-9. J Immunol 171: 3278-3286.
27. Velinov N, Poptodorov G, Gabrovski N, Gabrovski S,. 2010. The role of matrixmetalloproteinases in the tumor growth and metastasis. Khirurgiia (Sofiia) 1: 44-49.
28. Wang HH, Hsieh HL, Wu CY, Sun CC, Yang CM,. 2009. Oxidized low-density lipoprotein induces matrix metalloproteinase-9 expression via a p42/p44 and JNK-dependent AP-1 pathway in brain astrocytes. Glia 57: 24-38.
29. Weng CJ, Yen GC,. 2012. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: Phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat Rev 38: 76-87.
30. Weng CJ, Chau CF, Hsieh YS, Yang SF, Yen GC,. 2008. Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Carcinogenesis 29: 147-156.
31. Wuthi-udomlert M, Grisanapan W, Luanratana O, Caichompoo W,. 2000. Antifungal activity of Curcuma longa grown in Thailand. Southeast Asian J Trop Med Public Health 31 (Suppl. 1): 178-182.
32. Zwiefel K, Janni W,. 2011. Current standards in the treatment of breast cancer. Med Monatsschr Pharm 34: 280-288 (quiz 289-90).